Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?

BACKGROUND: Investigate the impact of the reduction of the number of target lesions on immune-related response assessment in advanced melanoma patients treated with ipilimumab. METHOD: Ninety patients (53 males, 37 females; age range: 25–87) with advanced melanoma treated with ipilimumab in two clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishino, Mizuki, Gargano, Maria, Suda, Margaret, Ramaiya, Nikhil H, Hodi, F Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077549/
https://www.ncbi.nlm.nih.gov/pubmed/24991412
http://dx.doi.org/10.1186/2051-1426-2-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077549/
https://www.ncbi.nlm.nih.gov/pubmed/24991412
http://dx.doi.org/10.1186/2051-1426-2-17

Ejemplares similares